Thomas Haughey, a director at ANI Pharmaceuticals ($ANIP), made one open market sale of company shares in the last year, totaling $1.66 million. His most recent transaction occurred on August 12, 2025. These sales rank 3,848th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions per insider. Haughey reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | HAUGHEY THOMAS | Director | S | Common Stock | 19341 | $85.93 | 36,521.0000 | 22,322,000 | 34.62% | 0.09% |
| May 22, 2025 | ANI PHARMACEUTICALS INC | $ANIP | HAUGHEY THOMAS | Director | A | Common Stock | 4336 | $0.00 | 55,862.0000 | 21,538,000 | 8.42% | 0.02% |
| May 21, 2024 | ANI PHARMACEUTICALS INC | $ANIP | HAUGHEY THOMAS | Director | A | Common Stock | 4410 | $0.00 | 51,526.0000 | 20,731,000 | 9.36% | 0.02% |
| May 23, 2023 | ANI PHARMACEUTICALS INC | $ANIP | HAUGHEY THOMAS | Director | A | Common Stock | 6865 | $0.00 | 47,116.0000 | 17,644,000 | 17.06% | 0.04% |